Andrew Holden: Update on the IN.PACT AV Access trial

942
Andrew Holden spoke to Vascular News at LINC 2018 (Leipzig Interventional Course; 30 January2 February, Leipzig, Germany) about the new data from the IN.PACT AV access trial and its significance, as well as Holden’s experience with the drug-coated balloon at his New Zealand centre.

(Visited 342 times, 1 visits today)

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.